Delivery Order SPE2DB25D2204-SPE2DB26FTFVK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $9,456.24 and a firm fixed price structure. This non-set-aside delivery order, which is due for completion by June 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Progesterone 200 mg capsules (100-count units) valued at $5,087.94 with firm fixed pricing. This non-competitive delivery order is set to conclude on September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,398.85. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is expected to be completed by August 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,562.35 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on October 23, 2025, with completion targeted for October 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $35,436.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,629.80. This firm fixed-price delivery order, which is scheduled for completion by October 30, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,101.48 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units, with a contract ceiling value of $9,247.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $9,205.95. This is a firm fixed price delivery order with an ultimate completion date of June 23, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $25,285.45. This firm fixed-price delivery order, which carries an ultimate completion date of July 29, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB26FTFVKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $8,960.40. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, executed without set-aside designation through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This specific delivery order for progesterone represents a routine pharmaceutical procurement under the company's established DLA prime vendor agreement, supporting ongoing medical supply needs for defense health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 10/29/25 |